Fifth Starr Cancer Consortium Grant Competition

(in alphabetical order by principal investigator)

  • "A Multidisciplinary Approach to the Study of an Oncogenic microRNA Cluster"

    Principal Investigator:

    • Andrea Ventura, MD, PhD, Memorial Sloan-Kettering Cancer Center

    Co-Principal Investigators:

    • Robert Darnell, MD, PhD, The Rockefeller University
    • Doron Betel, PhD, Weill Cornell Medical College

    Abstract 

  • "Proteomic Analysis of Proximal Pulmonary Venous Blood Identifies Biomarkers for Non-Small Cell Lung Cancer"

    Principal Investigator:

    • Brendon Stiles, MD, Weill Cornell Medical College

    Co-Principal Investigators:

    • Raffaella Sordella, PhD, Cold Spring Harbor Laboratory
    • Darryl Pappin, PhD, Cold Spring Harbor Laboratory
    • Olivier Elemento, PhD, Weill Cornell Medical College

    Abstract 

  • "Discovery of Prostate Cancer Tumor Suppressors and Treatment Biomarkers through in vivo RNA Interference Screens"

    Principal Investigator:

    • Charles Sawyers, MD, Memorial Sloan-Kettering Cancer Center

    Co-Principal Investigator:

    • Gregory Hannon, PhD, Cold Spring Harbor Laboratory

    Abstract 

  • "Functions and Mechanisms of E-box-binding Transcription Factors in AML 1-ETO-mediated Leukemogenesis"

    Principal Investigator:

    • Robert Roeder, PhD, The Rockefeller University

    Co-Principal Investigators:

    • Dinshaw Patel, PhD, Memorial Sloan-Kettering Cancer Center
    • Stephen Nimer, MD, Memorial Sloan-Kettering Cancer Center

    Abstract 
  • "Genomic and Epigenetics Changes Occurring During Carcinogenesis: A Fly Perspective"

    Principal Investigator:

    • Norbert Perrimon, PhD, The Broad Institute of MIT and Harvard

    Co-Principal Investigator:

    • Gregory Hannon, PhD, Cold Spring Harbor Laboratory

    Abstract 

  • "Transforming Genomics Data Visualization for Cancer Research"

    Principal Investigator:

    • Jill P. Mesirov, PhD, The Broad Institute of MIT and Harvard

    Co-Principal Investigators:

    • Chris Sander, PhD, Memorial Sloan-Kettering Cancer Center
    • Mark Rubin, MD, Weill Cornell Medical College

    Abstract 

  • "Genomewide Discovery of Novel Cancer Predisposing Mutations"

    Principal Investigator:

    • Steven Lipkin, MD, PhD, Weill Cornell Medical College

    Co-Principal Investigators:

    • David Altshuler, MD, PhD, The Broad Institute of MIT and Harvard
    • Mark Daly, PhD, The Broad Institute of MIT and Harvard
    • Kenneth Offit, MD, Memorial Sloan-Kettering Cancer Center

    Abstract 

  • "Developing Fascin Inhibitors to Block Tumor Metastasis"

    Principal Investigator:

    • Xin-Yun Huang, PhD, Weill Cornell Medical College

    Co-Principal Investigators:

    • J. David Warren, PhD, Weill Cornell Medical College
    • J. Fraser Glickman, PhD, The Rockefeller University

    Abstract 

  • "Genome Wide Profiling of Single Cells for Diagnosis and Monitoring in Prostate Cancer"

    Principal Investigator:

    • James Hicks, PhD, Cold Spring Harbor Laboratory

    Co-Principal Investigators:

    • Charles Sawyers, MD, Memorial Sloan-Kettering Cancer Center
    • Howard Scher, MD, Memorial Sloan-Kettering Cancer Center
    • Michael Wigler, PhD, Cold Spring Harbor Laboratory

    Abstract 

  • "Novel Approaches to Target High Grade Ovarian Cancers"

    Principal Investigator:

    • William C. Hahn, MD, PhD, The Broad Institute of MIT and Harvard

    Co-Principal Investigators:

    • Malcolm A.S. Moore, DPhil, Memorial Sloan-Kettering Cancer Center
    • Robert Benezra, PhD, Memorial Sloan-Kettering Cancer Center
    • Sangeeta Bhatia, MD, PhD, The Broad Institute of MIT and Harvard

    Abstract 
  • "An Integrated Host and Pathogen Genetic Strategy to Elucidate the Mechanism of Action of BCG in Therapy of Bladder Cancer"

    Principal Investigator:

    • Michael Glickman, MD, Memorial Sloan-Kettering Cancer Center

    Co-Principal Investigators:

    • William C. Hahn, MD, PhD, The Broad Institute of MIT and Harvard
    • David Root, PhD, The Broad Institute of MIT and Harvard
    • Eric Rubin, MD, PhD, The Broad Institute of MIT and Harvard

    Abstract 

  • "Systematic Studies of Resistance to Targeted Anticancer Therapeutics and Combinations"

    Principal Investigator:

    • Levi Garraway, MD, PhD, The Broad Institute of MIT and Harvard

    Co-Principal Investigators:

    • Boris Bastian, MD, PhD, Memorial Sloan-Kettering Cancer Center
    • Gary K. Schwartz, MD, Memorial Sloan-Kettering Cancer Center
    • David Root, PhD, The Broad Institute of MIT and Harvard
    • Michael Berger, PhD, Memorial Sloan-Kettering Cancer Center

    Abstract 
  • "Novel Treatment Strategies for Glioblastoma Using AAV-mediated CNS Gene Transfer of Monoclonal Antibodies"

    Principal Investigator:

    • Ronald Crystal, MD, Weill Cornell Medical College

    Co-Principal Investigator:

    • Viviane Tabar, MD, Memorial Sloan-Kettering Cancer Center

    Abstract 

  • "Activation of Natural RTK Inhibitors in Cancer Therapy"

    Principal Investigator:

    • Luca Cartegni, PhD, Memorial Sloan-Kettering Cancer Center

    Co-Principal Investigator:

    • Raffaella Sordella, PhD, Cold Spring Harbor Laboratory 

    Abstract 

  • "Bromodomain Inhibition as Targeted Therapy in Acute Myeloid Leukemia"

    Principal Investigators:

    • James Bradner, MD, The Broad Institute of MIT & Harvard

    Co-Principal Investigators:

    • Stephen D. Nimer, MD, Memorial Sloan-Kettering Cancer Center
    • Christopher R. Vakoc, MD, PhD, Cold Spring Harbor Laboratory

    Abstract 
  • "Investigation of the ATRX-Daxx Chromatin-remodeling Complex in Pancreatic Neuroendocrine Tumors"

    Principal Investigator:

    • C. David Allis, PhD, The Rockefeller University

    Co-Principal Investigators:

    • Laura Tang, MD, PhD, Memorial Sloan-Kettering Cancer Center
    • James Hsieh, MD, PhD, Memorial Sloan-Kettering Cancer Center
    • Dinshaw Patel, PhD, Memorial Sloan-Kettering Cancer Center

    Abstract